Table 2.
Characteristics of participants aged 60 years and older from the National Health and Nutrition Examination Survey (NHANES) (2011–2014).
| Characteristics |
NO HYP (N = 698) |
Controlled HYP (N = 890) |
Low uncontrolled HYP (N = 629) | High uncontrolled HYP (N = 261) | P -value |
|---|---|---|---|---|---|
| Age, years | 68.11 ± 6.48 | 69.22 ± 6.64 | 69.97 ± 6.77 | 71.73 ± 7.07 | <0.001 |
| Sex-female, n (%) | 325 (46.6) | 458 (51.5) | 314 (49.9) | 147 (56.3) | 0.042 |
| Ethnicity, n (%) | <0.001 | ||||
| Non-Hispanic White | 385 (55.2) | 453 (50.9) | 285 (45.3) | 117 (44.8) | |
| Non-Hispanic Black | 93 (13.3) | 231 (26.0) | 162 (25.8) | 76 (29.1) | |
| Mexican American/Hispanic | 82 (11.7) | 78 (8.8) | 70 (11.1) | 24 (9.2) | |
| Other | 138 (19.8) | 128 (14.4) | 112 (17.8) | 44 (16.9) | |
| Education-higher than high school, n (%) | 551 (78.9) | 664 (74.6) | 471 (74.9) | 185 (70.9) | 0.046 |
| Marital status-married, n (%) | 403 (57.7) | 506 (56.9) | 339 (53.9) | 135 (51.7) | 0.246 |
| Body mass index, kg/m2 | 27.72 ± 5.74 | 30.65 ± 6.48 | 28.89 ± 6.35 | 27.87 ± 5.67 | <0.001 |
| Smoking, n (%) | 0.041 | ||||
| Never | 342 (49.0) | 421 (47.3) | 310 (49.3) | 132 (50.6) | |
| Former | 266 (38.1) | 373 (41.9) | 221 (35.1) | 91 (34.9) | |
| Current | 90 (12.9) | 96 (10.8) | 98 (15.6) | 38 (14.6) | |
| Dietary fiber, g/day | 18.07 ± 10.19 | 16.39 ± 8.41 | 16.96 ± 8.97 | 15.90 ± 8.40 | 0.001 |
| Sport, n (%) | <0.001 | ||||
| Low > 150 | 312 (44.7) | 502 (56.4) | 354 (56.3) | 142 (54.4) | |
| High ≤ 150 | 386 (55.3) | 388 (43.6) | 275 (43.7) | 119 (45.6) | |
| Total cholesterol /High density lipoprotein cholesterol | 3.79 ± 1.21 | 3.69 ± 1.14 | 3.79 ± 1.26 | 3.86 ± 1.35 | 0.120 |
| Diabetes diagnosis, n (%) | <0.001 | ||||
| Absence | 563 (80.7) | 575 (64.6) | 443 (70.4) | 167 (64.0) | |
| Presence | 135 (19.3) | 315 (35.4) | 186 (29.6) | 94 (36.0) | |
| Cardiovascular disease diagnosis, n (%) | |||||
| Absence | 607 (87.0) | 635 (71.3) | 498 (79.2) | 196 (75.1) | <0.001 |
| Presence | 91 (13.0) | 255 (28.7) | 131 (20.8) | 65 (24.9) | |
| Antihypertensive drugs, n (%) | |||||
| Absence | 698 (100.0) | 79 (8.9) | 256 (40.7) | 88 (33.7) | <0.001 |
| Presence | 0 (0.0) | 811 (91.1) | 373 (59.3) | 173 (66.3) | |
| Hypoglycemic agents, n (%) | |||||
| Absence | 605 (86.7) | 652 (73.3) | 496 (78.9) | 198 (75.9) | <0.001 |
| Presence | 93 (13.3) | 238 (26.7) | 133 (21.1) | 63 (24.1) | |
| Lipid-lowering drugs, n (%) | |||||
| Absence | 495 (70.9) | 396 (44.5) | 368 (58.5) | 164 (62.8) | <0.001 |
| Presence | 203 (29.1) | 494 (55.5) | 261 (41.5) | 97 (37.2) | |
| Antiplatelet drugs, n (%) | |||||
| Absence | 676 (96.8) | 807 (90.7) | 594 (94.4) | 243 (93.1) | <0.001 |
| Presence | 22 (3.2) | 83 (9.3) | 35 (5.6) | 18 (6.9) | |